Literature DB >> 14704128

Effects of acetazolamide and anordiol on osmotic water permeability in AQP1-cRNA injected Xenopus oocyte.

Bing Ma1, Yang Xiang, Sheng-Mei Mu, Tao Li, He-Ming Yu, Xue-Jun Li.   

Abstract

AIM: To study the effects of acetazolamide and anordiol on osmotic water permeability in aquaporin 1 (AQP1)-cRNA injected Xenopus oocyte and their mechanisms.
METHODS: AQP1 gene constructed in pBluescript was transcripted into cRNA in vitro and then the cRNA was injected in Xenopus oocytes. The effects of acetazolamide and anordiol on the water transport function of AQP1 were observed by assaying the osmotic swelling of oocytes. In addition, their effects on protein expression of AQP1 were quantitatively investigated by Western blotting method.
RESULTS: After incubation for 15 min or 72 h, acetazolamide, a carbonic anhydrase inhibitor, equally reduced the water permeability of AQP1-cRNA injected oocyte in a dose-dependent manner. After incubation for 72 h, anordiol, an antiestrogen with partial estrogenic activity, reduced the osmotic water permeability dose dependently as well; however, no discernable action was observed after incubation with anordiol for 15 min. The Western blotting analysis showed that acetazolamide did not influence the protein expression of AQP1. However, after incubation for 72 h with anordiol (10 micromol/L), the quantity of AQP1 in the oocyte membrane was decreased dramatically (P<0.05).
CONCLUSION: Both acetazolamide and anordiol inhibited the osmotic water permeability of AQP1-cRNA injected oocyte, but their mechanisms were different. Acetazolamide functionally inhibited the osmotic water permeability of AQP1, whereas anordiol primarily decreased the amount of AQP1 protein in the oocyte membrane.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704128

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  25 in total

1.  Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents.

Authors:  Pallab Bhattacharya; Anand Kumar Pandey; Sudip Paul; Ranjana Patnaik; Dileep R Yavagal
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

2.  Test of blockers of AQP1 water permeability by a high-resolution method: no effects of tetraethylammonium ions or acetazolamide.

Authors:  Rikke Søgaard; Thomas Zeuthen
Journal:  Pflugers Arch       Date:  2007-11-28       Impact factor: 3.657

Review 3.  Aquaporins: translating bench research to human disease.

Authors:  A S Verkman
Journal:  J Exp Biol       Date:  2009-06       Impact factor: 3.312

4.  Aquaporins: relevance to cerebrospinal fluid physiology and therapeutic potential in hydrocephalus.

Authors:  Brian K Owler; Tom Pitham; Dongwei Wang
Journal:  Cerebrospinal Fluid Res       Date:  2010-09-22

5.  Automated cell-based assay for screening of aquaporin inhibitors.

Authors:  Maria Grazia Mola; Grazia Paola Nicchia; Maria Svelto; David C Spray; Antonio Frigeri
Journal:  Anal Chem       Date:  2009-10-01       Impact factor: 6.986

6.  Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site.

Authors:  Elton Migliati; Nathalie Meurice; Pascale DuBois; Jennifer S Fang; Suma Somasekharan; Elizabeth Beckett; Gary Flynn; Andrea J Yool
Journal:  Mol Pharmacol       Date:  2009-04-29       Impact factor: 4.436

7.  Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides.

Authors:  Baoxue Yang; Hua Zhang; A S Verkman
Journal:  Bioorg Med Chem       Date:  2008-06-10       Impact factor: 3.641

8.  Acetazolamide attenuates transvascular fluid flux in equine lungs during intense exercise.

Authors:  Modest Vengust; Henry Staempfli; Laurent Viel; Erik R Swenson; George Heigenhauser
Journal:  J Physiol       Date:  2013-07-01       Impact factor: 5.182

9.  Potential utility of aquaporin modulators for therapy of brain disorders.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 10.  Aquaporins: important but elusive drug targets.

Authors:  Alan S Verkman; Marc O Anderson; Marios C Papadopoulos
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.